<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN">
<html>

<!-- Mirrored from www.naturesbounty.com/vf/healthnotes/HN_Live/Spanish/Es-Concern/Congestive_Heart.ref.htm by HTTrack Website Copier/3.x [XR&CO'2005], Thu, 03 Mar 2005 14:30:38 GMT -->
<head>
<meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1">
<meta name="Language" content="es">
<meta name="ContentID" content="1193009">
<meta name="Category" content="Concern">
<meta name="Article" content="Congestive_Heart">
<title>Insuficiencia Cardiaca Congestiva-Referencias</title>
<link type="text/css" rel="stylesheet" href="../Styles/hnqrHtml.css">
<base target="_self">
</head>
<body>
<div id="Article-Title" class="Article-Title"><a name="Article-Title"></a> 

<p class="Article-Title">Insuficiencia Cardiaca Congestiva</p>
</div>

<div id="Reference-List" class="Reference-List">
<p class="Reference-Autofill"><a href="Congestive_Heart.htm">Volver al
art&#237;culo.</a></p>

<h3>Referencias para el art&#237;culo</h3>

<ol class="Reference-List">
<li class="Ref">Coats AJS. Effects of physical training in chronic heart failure. <em>
Lancet</em> 1990;335:63&#8211;6.</li>

<li class="Ref">Oka RK, De Marco T, Haskell WL, et al. Impact of a home-based walking and
resistance training program on quality of life in patients with heart failure. <em>Am J
Cardiol</em> 2000;85:365&#8211;9.</li>

<li class="Ref">Belardinelli R, Georgiou D, Cianci G, Purcaro A. Randomized, controlled trial
of long-term moderate exercise training in chronic heart failure. <em>Circulation</em>
1999;99:1173&#8211;82.</li>

<li class="Ref">Page J, Henry D. Consumption of NSAIDs and the development of congestive heart
failure in elderly patients. <em>Arch Intern Med</em> 2000;160:777&#8211;84.</li>

<li class="Ref">Bartels GL, Remme WJ, Pillay M, et al. Effects of L-propionylcarnitine on
ischemia-induced myocardial dysfunction in men with angina pectoris. <em>Am J Cardiol</em>
1994;74:125&#8211;30.</li>

<li class="Ref">Suzuki Y, Masumura Y, Kobayashi A, et al. Myocardial carnitine deficiency in
chronic heart failure. <em>Lancet</em> 1982;i:116 (letter).</li>

<li class="Ref">Mancini M, Rengo F, Lingetti M, et al. Controlled study on the therapeutic
efficacy of propionyl-L-carnitine in patients with congestive heart failure. <em>
Arzneimittelforschung</em> 1992;42:1101&#8211;4.</li>

<li class="Ref">Pucciarelli G, Mastursi M, Latte S, et al. The clinical and hemodynamic
effects of propionyl-L-carnitine in the treatment of congestive heart failure. <em>Clin
Ther</em> 1992;141:379&#8211;84.</li>

<li class="Ref">Kobayashi A, Masumura Y, Yamazaki N. L-carnitine treatment for congestive
heart failure&#8212;experimental and clinical study. <em>Jpn Circ J</em>
1992;56:86&#8211;94.</li>

<li class="Ref">Bashir Y, Sneddon JF, Staunton A, et al. Effects of long-term oral magnesium
chloride replacement in congestive heart failure secondary to coronary artery disease. <em>Am
J Cardiol</em> 1993;72:1156&#8211;62.</li>

<li class="Ref">Packer M, Gottlieb SS, Kessler PD. Hormone-electrolyte interactions in the
pathogenesis of lethal cardiac arrhythmias in patients with congestive heart failure. <em>Am J
Med</em> 1986;80 (Suppl 4A):23&#8211;9.</li>

<li class="Ref">Azuma J, Sawamura A, Awata N, et al. Double-blind randomized crossover trial
of taurine in congestive heart failure. <em>Curr Ther Res</em> 1983;34(4):543&#8211;57.</li>

<li class="Ref">Azuma J, Hasegawa H, Sawamura N, et al. Taurine for treatment of congestive
heart failure. <em>Int J Cardiol</em> 1982;2:303&#8211;4.</li>

<li class="Ref">Azuma J, Hasegawa H, Sawamura A, et al. Therapy of congestive heart failure
with orally administered taurine. <em>Clin Ther</em> 1983;5(4):398&#8211;408.</li>

<li class="Ref">Azuma J, Takihara K, Awata N, et al. Taurine and failing heart: experimental
and clinical aspects. <em>Prog Clin Biol Res</em> 1985;179:195&#8211;213.</li>

<li class="Ref">Mortensen SA, Vadhanavikit S, Baandrup U, Folkers K. Long-term coenzyme Q10
therapy: a major advance in the management of resistant myocardial failure. <em>Drug Exptl
Clin Res</em> 1985;11:581&#8211;93.</li>

<li class="Ref">Folkers K, Langsjoen P, Langsjoen PH. Therapy with coenzyme Q10 of patients in
heart failure who are eligible or ineligible for a transplant. <em>Biochem Biophys Res
Commun</em> 1992;15:247&#8211;53.</li>

<li class="Ref">Morisco C, Trimarco B, Condorelli M. Effect of coenzyme Q10 in patients with
congestive heart failure: a long-term multicenter randomized study. <em>Clin Invest</em>
1993;71:S134&#8211;6.</li>

<li class="Ref">Soja AM, Mortensen SA. Treatment of chronic cardiac insufficiency with
coenzyme Q10, results of meta-analysis in controlled clinical trials. <em>Ugeskr Laeger</em>
1997;159:7302&#8211;8.</li>

<li class="Ref">Hofman-Bang C, Rehnqvist N, Swedberg K, et al. Coenzyme Q10 as an adjunctive
in the treatment of chronic congestive heart failure. The Q10 Study Group. <em>J Card
Fail</em> 1995;1:101&#8211;7.</li>

<li class="Ref">Permanetter B, Rossy W, Klein G, et al. Ubiquinone (coenzyme Q10) in the
long-term treatment of idiopathic dilated cardiomyopathy. <em>Eur Heart J</em>
1992;13:1528&#8211;33.</li>

<li class="Ref">Watson PS, Scalia GM, Galbraith A, et al. Lack of effect of coenzyme Q on left
ventricular function in patients with congestive heart failure. <em>J Am Coll Cardiol</em>
1999;33:1549&#8211;52.</li>

<li class="Ref">Khatta M, Alexander BS, Krichten CM, et al. The effect of coenzyme Q10 in
patients with congestive heart failure. <em>Ann Intern Med</em> 2000;132:636&#8211;40.</li>

<li class="Ref">Mortensen SA, Vadhanavikit S, Baandrup U, Folkers K. Long-term coenzyme Q10
therapy: a major advance in the management of resistant myocardial failure. <em>Drug Exptl
Clin Res</em> 1985;11:581&#8211;93.</li>

<li class="Ref">Rector TS, Bank A, Mullen KA, et al. Randomized, double-blind, placebo
controlled study of supplemental oral L-arginine in patients with heart failure. <em>
Circulation</em> 1996;93:2135&#8211;41.</li>

<li class="Ref">Watanabe G, Tomiyama H, Doba N. Effects of oral administration of L-arginine
on renal function in patients with heart failure. <em>J Hypertens</em>
2000;18:229&#8211;34.</li>

<li class="Ref">Andrews R, Greenhaff P, Curtis S, et al. The effect of dietary creatine
supplementation on skeletal muscle metabolism in congestive heart failure. <em>Eur Heart
J</em> 1998;19:617&#8211;22.</li>

<li class="Ref">Gordon A, Hultman E, Kaijser L, et al. Creatine supplementation in chronic
heart failure increases skeletal muscle creatine phosphate and muscle performance. <em>
Cardiovasc Res</em> 1995;30:413&#8211;8.</li>

<li class="Ref">Moriyama Y, Yasue H, Yoshimura M, et al. The plasma levels of
dehydroepiandrosterone sulfate are decreased in patients with chronic heart failure in
proportion to the severity. <em>J Clin Endocrinol Metab</em> 2000;85:1834&#8211;40.</li>

<li class="Ref">Leuchtgens H. <em>Crataegus</em> special extract (WS 1442) in cardiac
insufficiency. <em>Fortschr Med</em> 1993;111:352&#8211;4.</li>

<li class="Ref">Schmidt U, Kuhn U, Ploch M, H&#252;bner WD. Efficacy of the hawthorn <em>
(Crataegus)</em> preparation LI 132 in 78 patients with chronic congestive heart failure
defined as NYHA functional class II. <em>Phytomed</em> 1994;1:17&#8211;24.</li>

<li class="Ref">Maevers VW, Hensel H. Changes in local myocardial blood flow following oral
administration of a <em>Crataegus</em> extract to non-anesthetized dogs. <em>
Arzneimittelforschung</em> 1974;24:783&#8211;5.</li>

<li class="Ref">Weikl A, Noh HS. The influence of <em>Crataegus</em> on global cardiac
insufficiency. <em>Herz Gerf&#228;sse</em> 1992; 11:516&#8211;24.</li>

<li class="Ref">Bahorun T, Trotin F, Pommery J, et al. Antioxidant activities of <em>Crataegus
monogyna</em> extracts. <em>Planta Med</em> 1994; 60:323&#8211;8.</li>

<li class="Ref">Schmidt U, Albrecht H, Podzuweit M, et al. High-dose crataegus therapy in
patients suffering from congestive heart failure NYHA class I and II. <em>Z Phytotherapie</em>
1998;19:22&#8211;30.</li>

<li class="Ref">Rietbrock N, Hamel M, Hempel B, et al. Actions of standardized extract of
Crataegus berries on exercise tolerance and quality of life in patients with congestive heart
failure [in German]. <em>Arzneimittelforschung</em> 2001;51:793&#8211;8.</li>

<li class="Ref">Lindner E, Dohadwalla AN, Bhattacharya BK. Positive inotropic and blood
pressure lowering activity of a diterpene derivative isolated from Coleus forskohli:
Forskolin. <em>Arzneimittelforschung.</em> 1978;28:284&#8211;9.</li>

<li class="Ref">Baumann G, Felix S, Sattelberger U, Klein G. Cardiovascular effects of
forskolin (HL 362) in patients with idiopathic congestive cardiomyopathy&#8212;a comparative
study with dobutamine and sodium nitroprusside. <em>J Cardiovasc Pharmacol</em>
1990;16:93&#8211;100.</li>

<li class="Ref">Kramer W, Thormann J, Kindler M, Schlepper M. Effects of forskolin on left
ventricular function in dilated cardiomyopathy. <em>Arzneimittelforschung</em>
1987;37:364&#8211;7.</li>

<li class="Ref">Bharani A, Ganguly A, Bhargava KD. Salutary effect of Terminalia Arjuna in
patients with severe refractory heart failure. <em>Int J Cardiol</em>
1995;49:191&#8211;9.</li>
</ol>
</div>
</body>

<!-- Mirrored from www.naturesbounty.com/vf/healthnotes/HN_Live/Spanish/Es-Concern/Congestive_Heart.ref.htm by HTTrack Website Copier/3.x [XR&CO'2005], Thu, 03 Mar 2005 14:30:38 GMT -->
</html>

